Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?
The intact parathyroid hormone (iPTH) assay is a critical test in the diagnosis and management of PTH-mediated hypercalcemia, including parathyroid carcinoma (PCa). We hypothesized that the survival of patients diagnosed with PCa has improved since adoption of the iPTH assay into clinical practice....
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
SAGE Publishing
2013-02-01
|
| Saila: | Rare Tumors |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.pagepress.org/journals/index.php/rt/article/view/4477 |